These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31982181)

  • 1. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
    Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
    Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
    Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
    Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland.
    Srinivasan A; Tuluc M; Jordan AJ; Curry JM; Bilyk JR
    Ophthalmic Plast Reconstr Surg; 2019; 35(2):e41-e43. PubMed ID: 30856630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.
    Kakkar A; Antony VM; Pramanik R; Sakthivel P; Singh CA; Jain D
    Hum Pathol; 2019 Jan; 83():59-67. PubMed ID: 30120966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
    Agaimy A; Rau TT; Hartmann A; Stoehr R
    Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
    Agaimy A
    Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
    Kohashi K; Oda Y
    Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
    Ayyanar P; Mishra P; Preetam C; Adhya AK
    Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma.
    Su YJ; Lee YH; Hsieh MS
    Pathol Int; 2022 Jan; 72(1):53-58. PubMed ID: 34597447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.
    Cheng JX; Tretiakova M; Gong C; Mandal S; Krausz T; Taxy JB
    Mod Pathol; 2008 Jun; 21(6):647-52. PubMed ID: 18327209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors.
    Zamecnik M; Rychnovsky J; Syrovatka J
    Int J Surg Pathol; 2018 May; 26(3):245-249. PubMed ID: 29166820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1/INI1-deficient tumors of adulthood.
    Parker NA; Al-Obaidi A; Deutsch JM
    F1000Res; 2020; 9():662. PubMed ID: 33796273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.
    Yoshida K; Fujiwara Y; Goto Y; Kohno T; Yoshida A; Tsuta K; Ohe Y
    BMC Cancer; 2018 Apr; 18(1):398. PubMed ID: 29625594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
    Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
    Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.